Gene: PHACTR1
Official Full Name: phosphatase and actin regulator 1provided by HGNC
Gene Summary: The protein encoded by this gene is a member of the phosphatase and actin regulator family of proteins. This family member can bind actin and regulate the reorganization of the actin cytoskeleton. It plays a role in tubule formation and in endothelial cell survival. Polymorphisms in this gene are associated with susceptibility to myocardial infarction, coronary artery disease and cervical artery dissection. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27435 | PHACTR1 Knockout cell line (HEK293) | Human | PHACTR1 | 1:3~1:6 | Negative | Online Inquiry |
PHACTR1 Gene Knockout Cell Lines are specifically engineered cellular models that allow researchers to study the functional roles of the PHACTR1 gene, which is implicated in various physiological processes and certain pathological conditions, such as vascular remodeling and migraine pathogenesis. By selectively disabling the PHACTR1 gene, these cell lines provide invaluable insights into gene expression patterns, cellular signaling pathways, and their contributions to disease mechanisms.
The key function of PHACTR1 gene knockout cell lines lies in their ability to facilitate precise genetic manipulation, enabling researchers to observe the effects of gene silencing on cellular behavior. Through techniques such as CRISPR-Cas9 technology, these knockout cell lines demonstrate a loss-of-function phenotype that can elucidate the biological role of PHACTR1 in various contexts. This mechanistic understanding is crucial for advancing therapeutic strategies targeting vascular disorders and migraines, where PHACTR1 plays a significant role.
Scientifically, these cell lines have broad applications in both basic research and clinical settings. They serve as experimental models to evaluate potential drug candidates, study disease mechanisms, and explore the pathways induced by the loss of PHACTR1 function. Furthermore, researchers investigating the genetic basis of vascular and neurological conditions can utilize these models to draw correlations between genetic deficiencies and phenotypic manifestations.
Compared to traditional wild-type cell lines, the PHACTR1 gene knockout cell lines offer a unique advantage by providing a more relevant context for studying gene function. This specificity allows for more accurate and reproducible results, thereby enhancing the reliability of experimental outcomes. Additionally, these cell lines can be further modified for use in high-throughput screening assays, promoting efficiency in drug discovery processes.
For researchers and clinicians, the PHACTR1 gene knockout cell lines represent a powerful tool for unraveling the complex interplay of genetics and disease, making it an essential asset in any molecular biology laboratory. With our company's expertise in developing cutting-edge biological products, we are committed to providing high-quality, reliable cell lines that empower science and accelerate research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.